Literature DB >> 1233236

Assay of the major (4-hydroxylated) metabolites of diphenylhydantoin in human urine.

B Karlén, M Garle, A Rane, M Gutova, B Lindborg.   

Abstract

A modified gas chromatographic procedure for the determination of unconjugated and conjugated 4-hydroxydiphenylhydantoin (4-OH-DPH) in urine has been developed. Unconjugated 4-OH-DPH is determined after selective extraction with toluene-ether (1:1). For the assay of conjugated 4-OH-DPH, the urine is pre-extracted with isoamylalcohol before acid hydrolysis to avoid interference by the dihydrodiol metabolite of DPH. The sensitivity of the method is 0.1 mug per ml. The method has been used to determine the urinary metabolites in two adult volunteers, during steady state plasma concentrations of DPH and in the elimination phase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233236     DOI: 10.1007/bf00562663

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  The metabolic fate of diphenylhydantoin in the dog, rat and man.

Authors:  E W MAYNERT
Journal:  J Pharmacol Exp Ther       Date:  1960-11       Impact factor: 4.030

2.  The metabolic conversion of 5, 5-diphenyl hydantoin to 5-(p-hydroxyphenyl)-5-phenyl hydantoin.

Authors:  T C BUTLER
Journal:  J Pharmacol Exp Ther       Date:  1957-01       Impact factor: 4.030

3.  Urinary excretion of diphenylhydantoin metabolites in newborn infants.

Authors:  A Rane
Journal:  J Pediatr       Date:  1974-10       Impact factor: 4.406

4.  Simultaneous determination of 5,5-diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin in serum, urine and tissues by gas-liquid chromatography after flash-heater methylation.

Authors:  A Estas; P A Dumont
Journal:  J Chromatogr       Date:  1973-08-01

5.  Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method.

Authors:  A Berlin; S Agurell; O Borgå; L Lund; F Sjöqvist
Journal:  Scand J Clin Lab Invest       Date:  1972-05       Impact factor: 1.713

6.  Identification of 5-meta-hydroxyphenyl-5-phenylhydantoin as a metabolite of diphenylhydantoin.

Authors:  A J Atkinson; J MacGee; J Strong; D Garteiz; T E Gaffney
Journal:  Biochem Pharmacol       Date:  1970-08       Impact factor: 5.858

7.  Gas chromatography of barbiturates, phenolic alkaloids, and xanthine bases: flash-heater methylation by means of trimethylanilinium hydroxide.

Authors:  E Brochmann-Hanssen; T O Oke
Journal:  J Pharm Sci       Date:  1969-03       Impact factor: 3.534

8.  Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration.

Authors:  A J Glazko; T Chang; J Baukema; W A Dill; J R Goulet; R A Buchanan
Journal:  Clin Pharmacol Ther       Date:  1969 Jul-Aug       Impact factor: 6.875

9.  The metabolism of 5,5-diphenylhydantoin (DPH) in nonpregnant and pregnant Rhesus monkeys.

Authors:  W L Gabler; G L Hubbard
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-05

10.  A 3-O-methylated catechol metabolite of diphenylhydantoin (Dilantin) in rat urine.

Authors:  T Chang; R A Okerholm; A J Glazko
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-07
View more
  3 in total

1.  Interaction between vigabatrin and phenytoin.

Authors:  E M Rimmer; A Richens
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of phenytoin.

Authors:  A Richens
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

Review 3.  Antiepileptic drugs. A review of clinically significant drug interactions.

Authors:  P N Patsalos; J S Duncan
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.